Faron Pharmaceuticals Oy (AIM:FARN)
55.00
-2.50 (-4.35%)
Feb 12, 2026, 4:35 PM GMT
Faron Pharmaceuticals Oy Employees
Faron Pharmaceuticals Oy had 32 employees as of June 30, 2025. The number of employees increased by 7 or 28.00% since the number was reported on December 31, 2024.
Employees
32
Change
7
Growth
28.00%
Revenue / Employee
n/a
Profits / Employee
-829.01K GBP
Market Cap
66.58M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Jun 30, 2025 | 32 | 7 | 28.00% |
| Dec 31, 2024 | 25 | -9 | -26.47% |
| Dec 31, 2023 | 34 | -6 | -15.00% |
| Dec 31, 2022 | 40 | 3 | 8.11% |
| Dec 31, 2021 | 37 | 7 | 23.33% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| hVIVO | 301 |
| 4basebio | 110 |
| Scancell Holdings | 60 |
| Arecor Therapeutics | 44 |
| SkinBioTherapeutics | 41 |
| Aptamer Group | 31 |
| Hemogenyx Pharmaceuticals | 16 |
| Poolbeg Pharma | 16 |
Faron Pharmaceuticals Oy News
- 1 day ago - Faron Pharmaceuticals Oy (FPHAF) Discusses Clinical Progress and Development Plans for BEXMAB in High-Risk MDS Transcript - Seeking Alpha
- 7 months ago - Faron Pharmaceuticals To Earn Spotlight At IUIS 2025 With Its Bexmarilimab Data - IBTimes